Problems viewing this newsletter? View it in your browser >

New On Our Blog

Our blog, P-Values, is where AVAC, our partners and colleagues in the field of HIV advocacy have their say about the latest findings, biggest challenges and most exciting successes in our collective work.

There have been many recent additions. Here are a few highlights:

Women Deserve to Know About HIV Prevention Medication Too
When taken correctly, PrEP has been shown to be equally effective in men and women. Yet why do media campaigns and clinical prescriptions continue to primarily target men who have sex with men? In a blog that originally appeared on Reproductive Health Reality Check, Dazon Dixon Diallo (SisterLove), Anna Forbes (HIV and reproductive health advocate) and Manju Chatani (AVAC) weigh in on PrEP for women.

Facing FACTS, and Just Getting on With It
Long-time microbicide advocate Jim Pickett reflects on the recent FACTS trial results. 

Decoding Cure Science: A CUREiculum webinar series
Want to learn more (or start learning!) about latency reversing agents, early treatment and engagement in cure research? These topics are the first three covered in a new webinar series based on the CUREiculum.

Playing Tennis Without a Net
Targets, goals and milestones are essential in measuring progress in the work to end the epidemic. PEPFAR’s lack of treatment and prevention targets to assess that impact (most notably VMMC) means PEPFAR may be playing tennis without a net.

Essential Power(ful) Points from CROI: Community delegates’ blogs
Don’t miss the rich, varied, thoughtful and opinionated blogs that have been written by advocates and activists working on the frontline of the AIDS epidemic in the US and globally.


HIV Prevention on the LineAVAC’s year-long series of web-based dialogues continues on Thursday, March 12 with a focus on oral PrEP results. To register for the call, click here. Download materials from the previous webinars via the link below. 


Forward This IssueDo you know someone who might be interested in receiving this newsletter?
Forward > 

Unsubscribe You're receiving this because you signed up for our newsletter. Not interested any longer?
Unsubscribe > 

Contact Us T: +1 212 796 6423